El hemostático de colágeno reduce el tiempo de hemostasia comparado con la celulosa

1. Czerny M., Verrel F., Weber H., et al:  Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction.  J Cardiovasc Surg 41. 553-557.2000;
2. Joseph T., Adeosun A., Paes T., et al:  Randomised controlled trial to evaluate the efficacy of TachoComb H patches in controlling PTFE suture-hole bleeding.  Eur J Vasc Endovasc Surg 27. 549-552.2004; 
3. Jackson M.R., Gillespie D.L., Longenecker E.G., et al:  Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial.  J Vasc Surg 30. 461-466.1999;
4. Taylor, Jr. , Jr.L.M., Mueller-Velten G., Koslow A., et al: Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts.  J Vasc Surg 38. 766-771.2003;
5. Tomizawa Y.:  Clinical benefits and risks analysis of topical haemostats: a review.  J Artif Organs 8. 137-142.2005;
6. Schonauer C., Tessitore E., Barbagallo G., et al:  The use of local agents: bone wax, gelatin, collagen, oxidized cellulose.  Eur Spine J 13. 89-96.2004;
7. Baumann P., Schumacher H., Hüsing J., et al:  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: “COBBANA” trial.  Trials 10. 91.2009;
8. Ereth M.H., Schaff M., Ericson E.F., et al:  Comparative safety and efficacy of topical hemostatic agents in arat neurosurgical model.  Neurosurgery 63. 369-372.2008; 
9. Engelhardt G.H., Gerhardt H.J., Nagelschmidt M.:  Action and biocompatibility of two collagen-based hemostatics in animal experiments.  Arzneimittelforschung 39. 259-262.1989; 
10. ünlü Y., Vural ü., Kocak H., et al:  Comparison of the topical haemostatic agents for the prevention of suture hole bleeding. An experimental study.  Eur J Vasc Endovasc Surg 23. 441-444.2002; 
11. Glickman M., Gheissari A., Money S., et al:  A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin.  Arch Surg 137. 326-331.2002; 
12. Haußmann P., Mergand U.E., Köhnlein H.E.:  Zur wirkung verschiedener hämostypitka.  Fortschr Med 13. 579-580.1974;
13. Bauer P., Köhne K.:  Evaluation of experiments with adaptive interim analysis.  Biometrics 50. 1029-1041.1994; 
14. Hougaard P.:  Fundamentals of survival data.  Biometrics 55. 13-22.1999; 
15. Keiding N., Andersen P.K., Klein J.P.:  The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates.  Stat Med 16. 215-224.1997; 
16. Rybock J.D., Long D.M.:  Use of microfibrillar collagen as a topical hemostatic agent in brain tissue.  J Neurosurg 46. 501-505.1977;
17. Wagner W.R., Pachence J.M., Ristich J., et al:  Comparative in vitro analysis of topical hemostatic agents.  J Surg Res 66. 100-108.1996;
18. Finn M.D., Schow S.R., Schneideman E.D.:  Osseous regeneration in the presence of four common hemostatic agents.  J Oral Maxillofac Surg 50. 608-612.1992;
19. Raccuia J.S., Simonian G., Dardik M., et al:  Comparative efficacy of topical hemostatic agents in a rat kidney model.  Am J Surg 163. 234-238.1992; 
20. Takács I., Wegmann J., Horváth S., et al:  Efficacy of different haemostatic devices for severe liver bleeding: a randomised controlled animal study.  Surg Innov 17. 346-352.2010; 
21. Johnson and Johnson: Tabotamp, Hämostyptikum zur sicheren lokalen Blutstillung. Gebrauchsanweisung, Hamburg June, 2005.
22. Haris W.H., Crothers O.D., Moyen B.J.L.:  Topical hemostatic agents for bone bleeding in humans.  J Bone Joint Surg Am 60. 454-456.1978;
23. Rengachary S.S., Manguoglou A.B.:  Control of bone bleeding during Cloward procedure.  J Neurosurg 52. 138-139.1980;
24. Craig C.C., Asher M.A.:  Hemostasis in human iliac crest donor sites with microfibrillar collagen.  Spine 2. 313-317.1977;
25. Silverstein M.E., Chvapil M.:  Experimental and clinical experience with collagen fleece as a hemostatic agent.  J Trauma 21. 388-393.1981;
26. Bland J.M., Bland D.G.:  Statistics notes: one and two sided tests of significance.  BMJ 309. 248.1994; 
27. Moher D., Schultz K.F., Altman D.G., et al:  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.  Lancet 14. 1191-1194.2001; 
28. Schwartz M., Madariaga J., Hirose R., et al:  Comparison of a new fibrin sealant with standard topical hemostatic agents.  Arch Surg 139. 1148-1154.2004; 
29. Chapman W.C., Clavien P.A., Fung J., et al:  Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial.  Arch Surg 135. 1200-1204.2000; 
30. Frilling A., Stavrou G.A., Mischinger H.J., et al:  Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.  Langenbecks Arch Surg 390. 114-120.2005; 
31. Siemer S., Lahme S., Altziebler S., et al:  Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study.  Eur Urol 52. 1156-1163.2007;